Literature DB >> 14666660

2B4(CD244)-mediated activation of NK cells reduces metastases of B16F10 melanoma in mice.

Lori A Johnson1, Swapnil V Vaidya, Ronald H Goldfarb, Porunelloor A Mathew.   

Abstract

BACKGROUND: Natural killer (NK) cells are a third population of lymphocytes that can kill certain tumor cells. This killing is regulated by signals received through activating and inhibitory receptors. 2B4 (CD244), a member of the CD2 subset of Immunoglobulin superfamily, was identified as an activating receptor on NK cells. Interaction of 2B4 with its ligand CD48 or anti-2B4 mAb stimulates NK cell cytolytic function as well as production of INF-gamma.
MATERIALS AND METHODS: A murine tumor model was used to study the in vivo role of 2B4. 2B4 and CD48 were activated in vivo by injecting anti-2B4 and anti-CD48 monoclonal antibodies.
RESULTS: Activation of 2B4 or CD48 resulted in a five-fold reduction in tumor metastasis. IFN-gamma knockout mice had a two-fold increase in metastasis as compared to wild-type after 2B4 activation.
CONCLUSION: Activation of 2B4 and CD48 reduces metastasis of B16F10 melanoma cells and this anti-tumor effect involves both cytolytic function and cytokine production.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14666660

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

Review 1.  The cancer-natural killer cell immunity cycle.

Authors:  Nicholas D Huntington; Joseph Cursons; Jai Rautela
Journal:  Nat Rev Cancer       Date:  2020-06-24       Impact factor: 60.716

Review 2.  Natural Killer Cells and Type 1 Innate Lymphoid Cells in Hepatocellular Carcinoma: Current Knowledge and Future Perspectives.

Authors:  Nicolas Jacquelot; Cyril Seillet; Fernando Souza-Fonseca-Guimaraes; Adrian G Sacher; Gabrielle T Belz; Pamela S Ohashi
Journal:  Int J Mol Sci       Date:  2021-08-22       Impact factor: 5.923

Review 3.  Signaling lymphocytic activation molecules Slam and cancers: friends or foes?

Authors:  Gregory Fouquet; Ingrid Marcq; Véronique Debuysscher; Jagadeesh Bayry; Amrathlal Rabbind Singh; Abderrahmane Bengrine; Eric Nguyen-Khac; Mickael Naassila; Hicham Bouhlal
Journal:  Oncotarget       Date:  2018-02-26

Review 4.  The Emerging Role of CD244 Signaling in Immune Cells of the Tumor Microenvironment.

Authors:  Laura Agresta; Kasper H N Hoebe; Edith M Janssen
Journal:  Front Immunol       Date:  2018-11-28       Impact factor: 7.561

5.  Candidate genes and pathways associated with brain metastasis from lung cancer compared with lymph node metastasis.

Authors:  Xuelian Zhao; Nan Wang; Tungamirai Chidanguro; Huanyu Gu; Yi Li; Huiru Cao; Pushuai Wen; Fu Ren
Journal:  Exp Ther Med       Date:  2019-06-26       Impact factor: 2.447

6.  MetastaSite: Predicting metastasis to different sites using deep learning with gene expression data.

Authors:  Somayah Albaradei; Abdurhman Albaradei; Asim Alsaedi; Mahmut Uludag; Maha A Thafar; Takashi Gojobori; Magbubah Essack; Xin Gao
Journal:  Front Mol Biosci       Date:  2022-07-22

7.  CD244 represents a new therapeutic target in head and neck squamous cell carcinoma.

Authors:  Laura Agresta; Maria Lehn; Kristin Lampe; Rachel Cantrell; Cassandra Hennies; Sara Szabo; Trisha Wise-Draper; Laura Conforti; Kasper Hoebe; Edith M Janssen
Journal:  J Immunother Cancer       Date:  2020-03       Impact factor: 13.751

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.